Wuhan Hiteck Biological Pharma Co Ltd Total Liabilities

Latest as of June 2026: CN¥381.30 Million CNY ≈ $55.80 Million USD

Wuhan Hiteck Biological Pharma Co Ltd total liabilities. Based on the latest financial reports, Wuhan Hiteck Biological Pharma Co Ltd (300683) has total liabilities worth CN¥381.30 Million CNY (≈ $55.80 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Wuhan Hiteck Biological Pharma Co Ltd (300683) asset resilience to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Wuhan Hiteck Biological Pharma Co Ltd (2013–2025)

Total liabilities of Wuhan Hiteck Biological Pharma Co Ltd from 2013 to 2025. This chart illustrates how Wuhan Hiteck Biological Pharma Co Ltd's total liabilities have evolved over time, based on quarterly financial data.

Wuhan Hiteck Biological Pharma Co Ltd Competitors by Total Liabilities

The table below lists competitors of Wuhan Hiteck Biological Pharma Co Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Bandwidth Inc NASDAQ:BAND	USA	$640.59 Million
RADIANCE HLDGS GRP.HD-01 F:RDH	Germany	€62.18 Billion
Intrepid Potash Inc NYSE:IPI	USA	$134.73 Million
Lungteh Shipbldg Co Ltd TW:6753	Taiwan	NT$5.81 Billion
Beijing Emerging Eastern Aviation Equipment Co Ltd Class A SHE:002933	China	CN¥708.72 Million
Citi Trends Inc NASDAQ:CTRN	USA	$370.85 Million
Jasmine International Public Company Limited BK:JAS-R	Thailand	฿6.65 Billion
Napatech A/S OL:NAPA	Norway	Nkr59.29 Million

Liability Composition Analysis (2013–2025)

This chart breaks down Wuhan Hiteck Biological Pharma Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Wuhan Hiteck Biological Pharma Co Ltd (300683) total assets.

Liquidity & Leverage Metrics

Wuhan Hiteck Biological Pharma Co Ltd Total Liabilities Ratios Explained

Wuhan Hiteck Biological Pharma Co Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	4.36	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.18	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.15	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Wuhan Hiteck Biological Pharma Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Wuhan Hiteck Biological Pharma Co Ltd (2013–2025)

The table below shows the annual total liabilities of Wuhan Hiteck Biological Pharma Co Ltd from 2013 to 2025.

Year	Total Liabilities	Change
2025-12-31	CN¥407.14 Million ≈ $59.58 Million	-22.46%
2024-12-31	CN¥525.05 Million ≈ $76.83 Million	+10.37%
2023-12-31	CN¥475.73 Million ≈ $69.61 Million	+28.16%
2022-12-31	CN¥371.20 Million ≈ $54.32 Million	+4.72%
2021-12-31	CN¥354.46 Million ≈ $51.87 Million	-23.21%
2020-12-31	CN¥461.62 Million ≈ $67.55 Million	+12.86%
2019-12-31	CN¥409.03 Million ≈ $59.85 Million	-8.24%
2018-12-31	CN¥445.77 Million ≈ $65.23 Million	+67.82%
2017-12-31	CN¥265.62 Million ≈ $38.87 Million	-20.91%
2016-12-31	CN¥335.87 Million ≈ $49.15 Million	+21.81%
2015-12-31	CN¥275.74 Million ≈ $40.35 Million	+4.14%
2014-12-31	CN¥264.78 Million ≈ $38.75 Million	+42.03%
2013-12-31	CN¥186.42 Million ≈ $27.28 Million	--

About Wuhan Hiteck Biological Pharma Co Ltd

SHE:300683 China Drug Manufacturers - Specialty & Generic

Market Cap

$413.73 Million

CN¥2.83 Billion CNY

Market Cap Rank

#12870 Global

#3755 in China

Share Price

CN¥21.60

Change (1 day)

-1.82%

52-Week Range

CN¥21.60 - CN¥48.78

All Time High

CN¥84.19